Médica Sur, S.A.B. de C.V.

Mexico Stock Exchange MEDICAB.MX

Médica Sur, S.A.B. de C.V. EBIT Margin for the year ending December 31, 2023: 19.78%

Médica Sur, S.A.B. de C.V. EBIT Margin is 19.78% for the year ending December 31, 2023, a 1.53% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Médica Sur, S.A.B. de C.V. EBIT Margin for the year ending December 31, 2022 was 19.48%, a -17.32% change year over year.
  • Médica Sur, S.A.B. de C.V. EBIT Margin for the year ending December 31, 2021 was 23.56%, a 74.21% change year over year.
  • Médica Sur, S.A.B. de C.V. EBIT Margin for the year ending December 31, 2020 was 13.53%, a 141.97% change year over year.
  • Médica Sur, S.A.B. de C.V. EBIT Margin for the year ending December 31, 2019 was 5.59%, a -50.09% change year over year.
Key data
Date EBIT Margin EPS (Basic) EPS (Diluted) Shares (Basic, Weighted)
Market news
Loading...
SV Wall Street
Mexico Stock Exchange: MEDICAB.MX

Médica Sur, S.A.B. de C.V.

CEO Dr. Carlos Arellano Quintana
IPO Date Jan. 4, 2000
Location Mexico
Headquarters Puente de Piedra 150
Employees 2,146
Sector Healthcare
Industries
Description

Médica Sur, S.A.B. de C.V. operates as a healthcare institution in Mexico. The company offers bypass and gastric banding, cholecystectomy, inguinal hernia repair, liposculpture, breast cosmetic, stereotactic radio, hip arthroplasty, knee arthroscopy, shoulder arthroscopy, spine, lithiasis, radical prostatectomy, and prostate surgeries. It also provides radiotherapy, imaging, and checkup services, as well as medical insurance services. The company was incorporated in 1966 and is based in Mexico City, Mexico. Médica Sur, S.A.B. de C.V. is a subsidiary of Neuco, SA de CV.

StockViz Staff

February 7, 2025

Any question? Send us an email